UK markets open in 3 hours 15 minutes
NIKKEI 225
37,780.35 +151.87 (+0.40%) HANG SENG
17,620.04 +335.50 (+1.94%) CRUDE OIL
83.82 +0.25 (+0.30%) GOLD FUTURES
2,345.10 +2.60 (+0.11%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,546.81 -16.41 (-0.03%)
Alkermes plc (ALKS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.65 |
| Open | 24.39 |
| Bid | 24.44 x 600 |
| Ask | 24.47 x 600 |
| Day's range | 23.89 - 24.60 |
| 52-week range | 22.01 - 33.71 |
| Volume | |
| Avg. volume | 2,016,338 |
| Market cap | 4.17B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 8.07 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
- Zacks
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Deciphera Pharmaceuticals (DCPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
© 2024 Yahoo. All rights reserved.